Cargando…

Eph Receptors and Ephrins in Retinal Diseases

Retinal diseases are the leading cause of irreversible blindness. They affect people of all ages, from newborns in retinopathy of prematurity, through age-independent diabetic retinopathy and complications of retinal detachment, to age-related macular degeneration (AMD), which occurs mainly in the e...

Descripción completa

Detalles Bibliográficos
Autores principales: Kaczmarek, Radoslaw, Gajdzis, Pawel, Gajdzis, Malgorzata
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8227845/
https://www.ncbi.nlm.nih.gov/pubmed/34201393
http://dx.doi.org/10.3390/ijms22126207
_version_ 1783712615965392896
author Kaczmarek, Radoslaw
Gajdzis, Pawel
Gajdzis, Malgorzata
author_facet Kaczmarek, Radoslaw
Gajdzis, Pawel
Gajdzis, Malgorzata
author_sort Kaczmarek, Radoslaw
collection PubMed
description Retinal diseases are the leading cause of irreversible blindness. They affect people of all ages, from newborns in retinopathy of prematurity, through age-independent diabetic retinopathy and complications of retinal detachment, to age-related macular degeneration (AMD), which occurs mainly in the elderly. Generally speaking, the causes of all problems are disturbances in blood supply, hypoxia, the formation of abnormal blood vessels, and fibrosis. Although the detailed mechanisms underlying them are varied, the common point is the involvement of Eph receptors and ephrins in their pathogenesis. In our study, we briefly discussed the pathophysiology of the most common retinal diseases (diabetic retinopathy, retinopathy of prematurity, proliferative vitreoretinopathy, and choroidal neovascularization) and collected available research results on the role of Eph and ephrins. We also discussed the safety aspect of the use of drugs acting on Eph and ephrin for ophthalmic indications.
format Online
Article
Text
id pubmed-8227845
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-82278452021-06-26 Eph Receptors and Ephrins in Retinal Diseases Kaczmarek, Radoslaw Gajdzis, Pawel Gajdzis, Malgorzata Int J Mol Sci Review Retinal diseases are the leading cause of irreversible blindness. They affect people of all ages, from newborns in retinopathy of prematurity, through age-independent diabetic retinopathy and complications of retinal detachment, to age-related macular degeneration (AMD), which occurs mainly in the elderly. Generally speaking, the causes of all problems are disturbances in blood supply, hypoxia, the formation of abnormal blood vessels, and fibrosis. Although the detailed mechanisms underlying them are varied, the common point is the involvement of Eph receptors and ephrins in their pathogenesis. In our study, we briefly discussed the pathophysiology of the most common retinal diseases (diabetic retinopathy, retinopathy of prematurity, proliferative vitreoretinopathy, and choroidal neovascularization) and collected available research results on the role of Eph and ephrins. We also discussed the safety aspect of the use of drugs acting on Eph and ephrin for ophthalmic indications. MDPI 2021-06-08 /pmc/articles/PMC8227845/ /pubmed/34201393 http://dx.doi.org/10.3390/ijms22126207 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Kaczmarek, Radoslaw
Gajdzis, Pawel
Gajdzis, Malgorzata
Eph Receptors and Ephrins in Retinal Diseases
title Eph Receptors and Ephrins in Retinal Diseases
title_full Eph Receptors and Ephrins in Retinal Diseases
title_fullStr Eph Receptors and Ephrins in Retinal Diseases
title_full_unstemmed Eph Receptors and Ephrins in Retinal Diseases
title_short Eph Receptors and Ephrins in Retinal Diseases
title_sort eph receptors and ephrins in retinal diseases
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8227845/
https://www.ncbi.nlm.nih.gov/pubmed/34201393
http://dx.doi.org/10.3390/ijms22126207
work_keys_str_mv AT kaczmarekradoslaw ephreceptorsandephrinsinretinaldiseases
AT gajdzispawel ephreceptorsandephrinsinretinaldiseases
AT gajdzismalgorzata ephreceptorsandephrinsinretinaldiseases